| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.09 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.086 | 0.1 |